CD52 is a glycosylphosphatidylinositol-anchored glycoprotein secreted by the epididymis where it is incorporated into sperm membranes. The antigen is common to spermatozoa and lymphocytes, and its role is not known. Quantitative analysis using immunostaining with the monoclonal antibody CAMPATH-1G and flow cytometry indicated positive signals from~80% of viable, washed ejaculated spermatozoa. Staining intensity increased after capacitation overnight, and decreased after short incubation with high density lipoprotein. After incubation of Percoll-washed spermatozoa with CAMPATH-1G, motility was reduced from 83 to 74% after 5 min and from 73 to 52% after 3.5 h. Swimming velocities were reduced by~30% and linearity by 15% in 5 min, but no further decreases were observed over 3.5 h. After 20 min incubation with the antibody, cell viability was decreased by 10 and 20% in freshly washed and capacitated spermatozoa respectively. Comparison of fertile and infertile patients revealed no difference in the percentages of immunostained spermatozoa or in staining intensity and there were no differences in sperm labelling between normozoospermia and teratozoospermia. Compared with normozoospermia, percentages of stained spermatozoa were lower by 20 and 27% in asthenozoospermia and oligozoospermia respectively, whereas staining intensity in asthenozoospermia was less than half that in oligozoospermia. The correlation of percentages of stained spermatozoa with percentages of motile cells suggests the involvement of epididymal CD52 in the maturation of sperm function.
Introduction
There is increasing evidence from animal studies that epididymis-specific proteins are involved in important aspects of fertilization (Cooper, 1995a) , but less is known of these proteins in man (Cooper, 1995b; Cooper and Yeung, 1997) . Despite reports of many human epididymis-specific genes (Kirchhoff, 1995) the functions of only a few of their translation products have been studied. AEGL1 (Hayashi et al., 1996) , the human equivalent of the rat epididymal protein D/E (also known as AEG and CRISP), is associated only loosely with the sperm surface (Krätzschmar et al., 1996) , suggesting that the role in sperm-vitellus fusion envisaged for this protein in the rat (Rochwerger and Cuasnicú, 1992 ) is less feasible in man. HE4 is another loosely bound epididymal protein that is removed from spermatozoa under capacitation conditions (Kirchhoff et al., 1991) . A further secreted protein appearing on human epididymal spermatozoa, FLB1, has been postulated to be involved in the acquisition of the capacity for spermoocyte fusion (Boué et al., 1995) while there is evidence that P34H, which disappears after the acrosome reaction, is probably involved in sperm-zona recognition . None of these proteins has been shown to be clinically relevant with the exception of P34H, whose absence from spermatozoa is associated with some cases of infertility .
In contrast to these epididymal proteins, the epididymal gene product HE5, which shares the peptide backbone of the lymphocyte surface antigen CD52 (Xia et al., 1991 (Xia et al., , 1993 Kirchhoff et al., 1993) , is attached firmly to the sperm membrane via its glycosylphosphatidylinositol (GPI)-anchor. Although CD52 has also been localized in the seminal vesicles (Hale et al., 1993) , there is no evidence of its secretion from this organ into the excurrent duct since CD52 is not detected in the ejaculates from vasectomized men (Rooney et al., 1996) . This antigen, in the presence of its antibody CAMPATH-1, is an especially good target for complement and the antibody has been used clinically to treat lympho-proliferative disorders (Hale et al., 1988) and to deplete lymphocytes in tissue transplants (see Ettenger and Yardin, 1995) . It also has been reported that recognition of CD52 on T lymphocytes by monoclonal antibodies leads to activation of cell proliferation via the CD2 pathway and expression of interleukin-2 receptors (Valentin et al. 1992) . However, the normal function of CD52 on lymphocytes in the absence of its antibodies is unknown. The unexpected expression of this gene in the human epididymis and the presence of the protein product in epididymal tissue and on spermatozoa in man (Hale et al., 1993; Kirchhoff, 1996) suggest a role in reproduction that awaits definition. Similar mRNA transcripts also have been identified in rats (Kirchhoff, 1994) , and are homologous with SMemG, the major maturation antigen in rat spermatozoa (Zeheb and Orr, 1984; Eccleston et al., 1994; Kirchhoff 1996) . As a corollary to recent studies on the maturational status of the human spermatozoa during acquisition of CD52 in the epididymis, and the mode of transfer of the protein , the present study examines the presence of CD52 on spermatozoa from patients attending an infertility clinic to see if it is related to any obvious physiological or pathological condition.
Materials and methods

Semen samples
The study population included normal and infertile men attending the Institute of Reproductive Medicine, Münster, Germany. All ejaculates used were obtained by masturbation and analysed after liquefaction for 30 min at 37°C according to the manual of the World Health Organization (WHO, 1992) . Selection of ejaculates and their semen parameters are described below for different parts of the study.
Staining of viable Percoll-washed spermatozoa for CD52 and analysis by flow cytometry All reagents were obtained from Sigma Chemie GmbH (Deisenhofen, Germany) unless otherwise stated. For the establishment of the method for staining CD52 on the surface of viable spermatozoa, 24 ejaculates with sperm concentrations Ͼ20ϫ10 6 /ml and motility (WHO grades aϩbϩc) Ͼ50% were used [initial semen volume, 4.4 Ϯ 0.3 ml (mean Ϯ SEM); sperm concentrations, 74.9 Ϯ 10.5ϫ10 6 /ml; motility, 63 Ϯ 2%; normal morphology, 21 Ϯ 2%]. A maximum of 1 ml semen was layered on 3 ml 35% (v/v) and 3 ml 70% (v/v) Percoll gradient and centrifuged at 500 g for 20 min. Sperm pellets were washed with 2 ml Ham's F-10 medium containing 4 mg bovine serum albumin (BSA)/ml by centrifugation at 450 g for 5 min and resuspended in that medium to a sperm concentration of 20ϫ10 6 /ml. Five µl of the monoclonal antibody CAMPATH1-G against CD52 [of rat immunoglobulin IgG2a isotype, a generous gift from Professor Geoffrey Hale, Therapeutic Antibody Centre, Oxford University] was added to 100 µl sperm suspension to a final dilution of 1:200 (protein concentration of the original antibody preparation at this dilution was 20 µg/ml). Rat serum IgG was added at an equivalent protein concentration to another sperm aliquot which was processed in parallel as a negative control for background subtraction. After incubation for 20 min at 37°C in 5% CO 2 , the spermatozoa were washed twice with 0.5 ml phosphate-buffered saline (PBS, containing BSA 4 mg/ml). In all washing steps in the immunostaining procedure, spermatozoa were pelleted by centrifugation at 2000 g at room temperature for 30 s (Ole Dich Centrifuge, Hvidore, Denmark). Staining with the secondary antibody was performed by resuspending the sperm pellet in 50 µl PBS to which 2.5 µl fluorescein isothiocyanate (FITC)-conjugated rabbit anti-rat IgG was added to a final dilution of 1:200. After a further incubation of 30 min at room temperature in the dark, the spermatozoa were washed once and resuspended in 0.5 ml PBS. Propidium iodide (PI; 12.5 µl of a stock solution of 200 µg/ml) was added to a final concentration of 5 µg/ml for the staining of non-viable cells. After 5 min in the dark, each sample was analysed by flow cytometry (Coulter Epics XL; Coulter Electronics GmbH, Krefeld, Germany) using laser light excitation at 488 nm and with forward and side scatter signals to set gatings for sperm cells. Fluorescence signals from~5000 spermatozoa at wavelengths for FITC (550DL dichroic filter and 525BP band pass filter) and PI (620BP filter) were detected without colour compensation, since spillover emissions from the FITC and PI signals into each other's 1046 detection channel were found to be negligible. Spermatozoa unstained for PI (viable) were gated and analysed for FITC signals. The cutoff level of FITC fluorescence for non-specific staining was determined from the signals of the paired control samples, which were stained with non-specific IgG, and the net percentages of positively stained cells were obtained by subtracting the control values.
Fluorescence microscopy
Washed and non-fixed ejaculated spermatozoa were prepared and stained for CD52 as described above. Spermatozoa in the final loose pellet without PI staining were smeared onto slides and air-dried. Slides were mounted with Sigma mounting medium and examined with an Olympus BX40 fluorescence microscope fitted with an excitation filter (BP450-480), a dichroic mirror (DM500) and a barrier filter (BA515).
Effect of CD52 antibody on washed sperm motility
Aliquots of freshly prepared Percoll-washed spermatozoa from 10 of the above ejaculates were used. These ejaculates had 69 Ϯ 16ϫ10 6 spermatozoa/ml, 68 Ϯ 3% motility and 24 Ϯ 4% normal morphology. Spermatozoa were incubated with CAMPATH-1G (1:200) or rat IgG (20 µg/ml) as a control, as described above. At 5 min, 20 min and 3.5 h, 5 µl samples were loaded into a Makler chamber (Sefi Medical Instruments, Haifa, Israel) and motility was recorded at 37°C by video-microscopy with pseudo-dark field illumination, ϫ10 objective and ϫ3.3 photo-occular. Kinematic parameters were analysed using the computer system HTM-C (Hamilton-Thorne Software Version 10.6H, Beverley, MA, USA) from 25 video-frames acquired at 25 Hz (see Yeung et al., 1996 for details), whereas percentage motility was assessed by direct microscopic observation.
Extraction of sperm surface CD52 by incubation with high density lipoprotein (HDL)
The surface component, CD52, was extracted using HDL from spermatozoa in ejaculates from seven patients, containing 99 Ϯ16ϫ10 6 spermatozoa/ml, with 68 Ϯ 3% motility and 28 Ϯ 6% normal morphology. Spermatozoa were washed as described above. HDL (Sigma L5277) was added to the sperm suspension at a final concentration of 1 mg/ml and incubated for 30 min at 37°C. After washing once in Ham's F-10 medium, the sperm pellet was dispersed and incubated a second time with fresh HDL-containing medium. Incubation and washing of another sperm aliquot without HDL was performed in parallel as control. After the second incubation and washing, the spermatozoa were stained with CAMPATH-1G or rat IgG and analysed by flow cytometry as described above.
CD52 staining of spermatozoa from groups of patients with different semen qualities
A total of 109 ejaculates was obtained from consecutive patients attending the clinic, excluding those with sperm concentrations Ͻ3ϫ10 6 /ml, which could not yield sufficient spermatozoa for the study. A 200-400 µl aliquot of each ejaculate was washed twice with Ham's F-10 medium, and pelleted spermatozoa were resuspended to a concentration of 10-40ϫ10 6 /ml and stained as described above. The major defect, if any, in the spermiograms of all the patients was teratozoospermia, with 56 patients having sperm morphology as the only abnormal semen parameter (Ͻ30% normal forms). Since the characteristics of staining for CD52 in these solely teratozoospermic samples were found to be identical to those in the normozoospermic samples (see Results), whether as one group or divided into teratozoospermia of severe (Ͻ15% normal form) and moderate (15-29% normal form) extents, the other patients with asthenoteratozoospermia and oligoteratozoospermia were grouped respectively into the astheno- zoospermic (Ͻ50% motility) and oligozoospermic (Ͻ20ϫ10 6 spermatozoa/ml) groups. Five oligoasthenozoospermic samples were placed into the oligozoospermia group. Semen parameters of the five different groups of subjects studied are summarized in Table I .
Statistical analysis
Analysis of variance (ANOVA) and linear regression were performed on data with or without transformation (arcsin square root for all data in percentages and logarithmic transformation for sperm concentrations). For sperm kinematic data, the median value of each parameter was obtained for each sample. The mean values of the treatment groups were calculated from these median values. For testing differences between data groups, the Wilcoxon Rank test was used for data with paired controls and Student-Newman-Keuls tests for different groups of patients. To facilitate reading, mean values of transformed data are given in the text and figures after converting back into the normal form, and the upward SEs shown were calculated as the differences between the retransformed (mean ϩ SEM) and mean values. 
Results
Surface staining for CD52 of spermatozoa from normozoospermic samples
The first experiment assessed the staining of the washed ejaculated spermatozoa by CAMPATH-1G. It was found that 79.6 ϩ 2.8% (retransformed mean ϩ upper SEM, n ϭ 24) of the viable spermatozoa (cells not stained by propidium iodide) showed positive fluorescence signals. The staining was localized largely on the post-acrosomal area and the tail (Figure 1) . The clumpy appearance of the surface FITC staining was probably a result of the indirect immunostaining of non-fixed cells (to retain sperm viability and ensure staining of surface antigens only) rather than the non-specificity of staining, since such staining was not observed when the primary antibody was replaced by rat IgG in the control in this study, or when the same staining protocol was applied to immature spermatozoa obtained from the epididymis before they acquire the protein . After incubation of the ejaculated spermatozoa overnight in capacitation conditions, the percentage of CD52-stained viable spermatozoa remained unchanged at 81.9 ϩ 3.5%. However, staining intensity increased from 10.0 Ϯ1.4 to 24.5 Ϯ 1.7 channel no. (P Ͻ 0.001). In both the fresh and the overnight incubated spermatozoa, there were slight, but significant, decreases in sperm viability upon incubation with CAMPATH-1G when compared with paired aliquots incubated with control IgG (a 10% decrease in fresh samples from 65.5 ϩ 3.4 to 55.0 ϩ 3.3% viable spermatozoa, and a decrease of~20% in overnight samples from 56.1 ϩ 5.9 to 38.6 ϩ 4.4%, P Ͻ 0.0001 in both).
Effect of CD52 antibody on sperm motility
When compared with the parallel incubation with control rat IgG, percentage motility was decreased slightly (by 9%), yet significantly after 5 min incubation with CAMPATH-1G. The significance of the decrease was not sustained after 20 min, whereas a more marked and significant decline of 21% was found after 3.5 h (Figure 2 ). Curvilinear velocities were decreased significantly at all three time points (by 29% of control values after 5 min and 20% after 3.5 h). More marked decreases in average path velocities and straight-line velocities were already detectable after 5 min (Figure 2 ) but did not change further with time. Decrease in linearity of swim-path was detected during the first 20 min but was not sustained on further incubation. The amplitude of lateral displacement of the sperm head was not affected until after 3.5 h of incubation (3.72 Ϯ 0.37 versus 4.33 Ϯ 0.46 µm in the control, P Ͻ 0.05). There was no effect on the beat cross frequency (data not shown). Some treated samples showed a slight degree of sperm agglutination (both head to tail and tail to tail) after 3.5 h of incubation.
Extraction of CD52 from spermatozoa by high density lipoprotein
This was performed to determine whether sperm CD52 shares transport characteristics with other GPI-anchored proteins (Väkevä et al., 1994) . After two incubations with high density lipoprotein (HDL), there was no significant change in the percentages of viable sperm cells expressing CD52, but a decrease was noted in the staining intensity of the HDL-incubated spermatozoa to 68 Ϯ 10% of control values (P Ͻ 0.02) measured in spermatozoa from paired control incubations (n ϭ 7) (Figure 3 ).
Expression of CD52 on spermatozoa from different groups of patients
Semen parameters of the different groups of subjects studied are summarized in Table I . Whereas spermatozoa from both groups of severe and moderate teratozoospermic patients had the same CD52 staining characteristics as those from Figure 4 . Correlations of CD52 staining of washed spermatozoa with semen parameters. Note that the data are plotted as percentages for illustration purposes while the regression analyses were performed on transformed data (see Table III for correlation coefficients).
normozoospermic men in terms of percentages of spermatozoa interacting with CAMPATH-1G and the staining intensity, asthenozoospermic and oligozoospermic samples showed significantly lower percentages of staining in both total and viable spermatozoa (Table I) . Staining intensity of sperm CD52 in the asthenozoospermic group showed a mean value below that of the normozoospermic group, whereas the oligozoospermic group showed a higher mean value than the normozoospermic group, although these differences were not statistically significant. However, the difference between the astheno-and the oligo-zoospermic groups was statistically significant (Table I , P Ͻ 0.05). There were no statistically significant differences among patients of different fertility status in the CD52 staining characteristics of their spermatozoa, nor in the semen parameters of their ejaculates (Table II) . When all 109 patients' data were analysed, positive correlations were found between the percentages of CD52-stained spermatozoa and certain semen parameters. These correlations were more evident when viable rather than total spermatozoa were considered (Table III) . Correlations with percentage motility were stronger than with sperm concentration or with percentage normal morphology (Figure 4) . There was also a significant correlation between the percentages of CD52-stained spermatozoa and motility within the group of asthenozoospermic patients (R ϭ 0.654, P ϭ 0.021). When all patients were considered, CD52 staining characteristics were not correlated with the number of round cells or leukocytes in the ejaculates. The presence of IgG or IgA on spermatozoa did not influence either the percentage of viable spermatozoa stained by CAMPATH-1G or the staining intensity (Table IV) .
Discussion
This study confirms previous reports that the lymphocyte antigen CD52 is present on human ejaculated spermatozoa (Hale et al., 1993; Kirchhoff, 1996) and extends them by quantifying the proportion of cells which express the antigen on their surfaces. An extremely high percentage of viable cells from the ejaculate were positive for the antigen, as would be expected from the similarly high percentage of positive spermatozoa from the cauda epididymidis since they acquire this epididymal secretory product during their transit . The low percentage of negative cells indicates the heterogeneity of human spermatozoa as shown in many other parameters such as motility and morphology, and may reflect defects in plasma membrane composition or maturation process, as the uptake of this GPI-linked protein requires a certain maturational status see below) . Furthermore, the surface antigen remained attached to the ejaculated spermatozoa during incubation under capacitating conditions, confirming its tight association with the sperm membranes, unlike another epididymal secretion, HE4, that is easily removed from the spermatozoa under these conditions (Kirchhoff et al., 1991) . The doubling of fluorescence intensity noted after such incubation may reflect an increased accessibility of the antibody to the peptide upon capacitation, but the cause and significance of this change are as yet unclear. The retention of CD52 on incubated spermatozoa suggests that it may be involved in survival and in the interaction with the female tract before fertilization, or in the removal of the remaining unfertilized spermatozoa from the tract after fertilization.
The role of CD52 on the lymphocyte surface is unknown. A recent study has shown that transfected Chinese hamster ovary cell lines which express different levels of CD52 exhibit different cell shapes and also differ in their growth when transplanted to nude mice, suggesting a role of this protein in cell adhesion and/or protection in the host environment . Whether CD52 on the sperm surface plays a lymphocyte mimicking role, or merely shares a common feature of a backbone peptide as a scaffold for rich carbohydrate residues (see Hale, 1995) , needs to be investigated.
As well as their use in localizing and quantifying membrane antigens, specific antibodies towards particular membrane proteins can be used to provide information about the functions of these proteins, and for spermatozoa, monitoring motility is an obvious approach. The viability of ejaculated spermatozoa incubated with CAMPATH-1, at concentrations not causing (channel no.) 12.9 Ϯ 2.0 11.6 Ϯ 0.9 14.9 Ϯ 3.2 11.5 Ϯ 0.9 a Values given are means Ϯ SEM or means ϩ SEM where statistical analysis was performed on transformed data and values were converted back to normal.
agglutination, was consistently but slightly decreased as detected by uptake of propidium iodide. This is in agreement with the significant but marginal reduction in percentage motility. Complexing of antibody with a membrane antigen could only damage the membrane if a gross distortion of it were brought about, but as the majority of spermatozoa remained intact, the affected population are probably dying spermatozoa that are especially responsive to this antibody binding. By using percentage motility as an index of cell viability Hale et al. (1993) found that the antibody had no obvious effect on spermatozoa in the absence of complement. By using computer-assisted semen analysis (CASA), moderate reductions in swimming velocities and linearity were determined in those sperm cells that remained motile. These findings highlight the difference between CAMPATH-1 and another small peptide which is recognized by the antibody GZS-1 raised to a sperm antigen that is found in the human epididymis and also on human monocytes (Hutter et al., 1996) . The latter antibody causes agglutination of spermatozoa which may have contributed to the inhibition of oocyte penetration by the treated spermatozoa. Little is known concerning the environment necessary for the transfer of CD52, with its GPI-anchor intact, to the sperm membrane within the epididymal duct (Kirchhoff and Hale, 1996) . Transfer of CD52 to corpus epididymidal spermatozoa from man and monkey can be effected in vitro by incubation in whole epididymal plasma or seminal plasma, but not by incubation in ultrafiltered fractions of these fluids , suggesting that either vesicular or high molecular weight components are necessary for uptake of CD52. Transfer of other GPI anchored complement regulatory proteins (e.g. CD59) may involve cell-cell contact (Kooyman et al., 1995) , membrane vesicles or micelle components (Rooney et al., 1993 (Rooney et al., , 1996 . It has been shown that CD59 on erythrocytes can be incorporated into high density lipoproteins (HDL) by incubation and reinserted into membranes of other non-labelled erythrocytes and endothelial cells which normally express the protein (Väkevä et al., 1994) . In the present study, such a role of HDL was proven feasible for sperm CD52 where staining intensity was significantly reduced after incubation of washed ejaculated spermatozoa with HDL.
The positive correlations between the percentage of sperm cells possessing CD52 on their surface with the sperm concentration in the ejaculate and the percentages of morphologically normal and motile cells probably reflect the overall quality of the male reproductive system. For example, larger epididymides that produce more secreted protein are more likely to be associated with a larger testis able to produce more normal spermatozoa that will take up the secretion.
When considering spermatozoa from men with semen of different pathologies, the extent of CD52 coating of morphologically abnormally spermatozoa in teratozoospermia was no different from that found in normozoospermia, whether considering all or only the viable cells. Thus, despite the abnormal morphology of spermatozoa, the cell membranes are obviously capable of taking up the protein within the epididymis, suggesting that the teratozoospermic patients appeared to have adequate epididymal function, as demonstrated by almost complete CD52 staining of mature sperm cells.
Although both the oligozoospermic and asthenozoospermic patients exhibited similar, but subnormal, percentages of spermatozoa expressing surface CD52, the underlying causes of infertility must be different, since the positive spermatozoa from the former group showed staining intensities double that of the latter, and the latter showed a tendency towards lower than normal values. It is likely that the defect of some spermatozoa from the oligozoospermic patients in taking up CD52 is caused by faulty spermatogenesis; in this case there would be surplus epididymal secretion to coat the remaining spermatozoa that do mature normally. On the other hand, abnormalities in staining properties of spermatozoa in asthenozoospermia could be of epididymal origin. It is interesting to note that the profile of the increase in gene expression for CD52 along the human epididymis ) is similar to the profile of motility development during epididymal transit (Yeung et al., 1993) , with both reaching the maximum in the distal corpus region. A relevant finding is the significant correlation between the percentage of CD52-positive spermatozoa and the percentage of motile spermatozoa within the asthenozoospermic group, which was greater than the correlation for all patients considered together. Currently, it is not possible to tell which of the following possibilities underlies the defect: (i) reduced epididymal secretion of the antigen; (ii) different glycosylation states of the secreted glycoprotein compromising access of the antibody; (iii) reduced high molecular weight factors necessary for transfer to the spermatozoa; or (iv) reduced ability of the sperm cell to associate with the glycoprotein. The latter ability has been demonstrated in vitro in monkeys to depend on the maturational state of the sperm cell, since corpus spermatozoa can take up CD52 from human seminal plasma but caput spermatozoa cannot .
Similarities in the characteristics of CD52 staining of ejaculated spermatozoa as well as semen quality, including percent-age motility between infertile men and those proved to be fertile, whether through spontaneous pregnancy or assisted reproduction, suggest that epididymal factors may not contribute to the cause of infertility in this cohort of patients.
The present study has characterized the association of the human epididymal secretion CD52 common to lymphocytes with ejaculated spermatozoa and analysed the expression of this antigen on spermatozoa from subfertile patients. Differences were revealed in different semen pathologies, but the causes of the differences are unclear. Further research on the role of this protein may reveal some relevance for clinical diagnosis.
